Recombinant human PDCD5 exhibits an antitumor role in hepatocellular carcinoma cells via clathrin-dependent endocytosis

被引：17
作者：
Fu, Da-Zhi [1 ]
Cheng, Ying [1 ]
He, Hui [1 ]
Liu, Hai-Yang [1 ]
Liu, Yong-Feng [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Gen Surg, Shenyang 110001, Liaoning, Peoples R China
来源：
MOLECULAR MEDICINE REPORTS | 2015年 / 12卷 / 06期
关键词：
hepatocellular carcinoma; recombinant human programmed cell death 5; prognosis; apoptosis; cyclin A; EXPRESSION; GENE; APOPTOSIS;
D O I：
10.3892/mmr.2015.4489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Liver cancer is the fifth most frequently diagnosed type of cancer in men worldwide. Recombinant human programmed cell death 5 (rhPDCD5) has been shown to enter a variety of cells by clathrin-independent endocytosis. Tissue specimens from 32 hepatocellular carcinoma (HCC) patients were collected for analysis of PDCD5 expression using ELISA. It was confirmed that the pre-operative serum levels of PDCD5 protein in patients with HCC were significantly lower than the post-operative serum levels. Moreover, the serum PDCD5 levels were significantly correlated with portal invasion and lymph node metastasis. rhPDCD5 inhibited cell proliferation as indicated by an MTT assay, and induced apoptosis and S-phase arrest in HCC cells as demonstrated by flow cytometric analysis. Furthermore, rhPDCD5 suppressed tumor growth in established xenograft tumor models. In addition, Pitstop2 was used to block clathrin-dependent endocytosis (CDE), which confirmed that the anti-tumor effect of rhPDCD5 in HCC cells is mediated via CDE.
引用
收藏
页码：8135 / 8140
页数：6
相关论文
共 14 条
[1]  
[Anonymous], 2020, CA Cancer J Clin, DOI DOI 10.3322/CAAC.21590
[2]   Mechanisms of Endocytosis [J].
Doherty, Gary J. ;
McMahon, Harvey T. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :857-902
[3]   Pitstop 2 Is a Potent Inhibitor of Clathrin-Independent Endocytosis [J].
Dutta, Dipannita ;
Williamson, Chad D. ;
Cole, Nelson B. ;
Donaldson, Julie G. .
PLOS ONE, 2012, 7 (09)
[4]   CURRENT CONCEPTS Hepatocellular Carcinoma [J].
El-Serag, Hashem B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) :1118-1127
[5]   Molecular model for a complete clathrin lattice from electron cryomicroscopy [J].
Fotin, A ;
Cheng, YF ;
Sliz, P ;
Grigorieff, N ;
Harrison, SC ;
Kirchhausen, T ;
Walz, T .
NATURE, 2004, 432 (7017) :573-579
[6]   PDCD5 expression predicts a favorable outcome in patients with hepatocellular carcinoma [J].
Fu, Da-Zhi ;
Cheng, Ying ;
He, Hui ;
Liu, Hai -Yang ;
Liu, Yong-Feng .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (03) :821-830
[7]   The anti-tumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells [J].
Han, Xiao-Rui ;
Sun, Yu ;
Bai, Xi-Zhuang .
CELLULAR SIGNALLING, 2012, 24 (08) :1713-1721
[8]   Gene-expression profiles in hereditary breast cancer. [J].
Hedenfalk, I ;
Duggan, D ;
Chen, YD ;
Radmacher, M ;
Bittner, M ;
Simon, R ;
Meltzer, P ;
Gusterson, B ;
Esteller, M ;
Kallioniemi, OP ;
Wilfond, B ;
Borg, Å ;
Trent, J ;
Raffeld, M ;
Yakhini, Z ;
Ben-Dor, A ;
Dougherty, E ;
Kononen, J ;
Bubendorf, L ;
Fehrle, W ;
Pittaluga, S ;
Gruvberger, S ;
Loman, N ;
Johannsoson, O ;
Olsson, H ;
Sauter, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (08) :539-548
[9]   TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal [J].
Liu, HT ;
Wang, YG ;
Zhang, YM ;
Song, QS ;
Di, CH ;
Chen, GH ;
Tang, J ;
Ma, DL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (01) :203-210
[10]   The cellular functions of clathrin [J].
Royle, S. J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (16) :1823-1832
12